Emulsi Biotech AB
1 known investors
Emulsi develops NanoLIPID™, a natural lipid technology that self-assembles into nano-structures for encapsulating active pharmaceutical ingredients, nutraceuticals, and bioactive compounds. The platform targets oral drug delivery, cosmetics, and nutraceutical applications.